Refine
Year of publication
Document Type
- Article (104)
- Preprint (9)
- Conference Proceeding (4)
- Contribution to a Periodical (3)
- Book (1)
- Working Paper (1)
Has Fulltext
- yes (122)
Is part of the Bibliography
- no (122)
Keywords
- COVID-19 (5)
- SARS-CoV-2 (4)
- Biomarkers (3)
- ACLF (2)
- Cirrhosis (2)
- Genetics (2)
- HCC (2)
- Immunology (2)
- Inflammation (2)
- NASH (2)
- risk factors (2)
- 2‑methoxyestradiol (1)
- ALK-rearranged NSCLC (1)
- AML (1)
- Acute inflammation (1)
- Acute myeloid leukemia (1)
- Advanced stage (1)
- Alzheimer’s dementia (1)
- Amyloid-beta 42 (1)
- Anal cancer (1)
- Antibiotic therapy (1)
- Artificial Intelligence (1)
- Assay variation (1)
- Aurora kinase (1)
- BCOR (1)
- BCORL1 (1)
- Biodiversity Data (1)
- Biomonitoring (1)
- Botanical Collections (1)
- Brain tumor (1)
- Burden of disease (1)
- CEP68 (1)
- CGD (1)
- CLIF-C ACLF score (1)
- CLIF-C ACLF-R score (1)
- COBAS Taqman (1)
- COMP (1)
- COVID 19 (1)
- CRISPR/Cas9 (1)
- CVD biomarker (1)
- Cancer (1)
- Cardiovascular disease (1)
- Cardiovascular disease risk (1)
- Cardiovascular diseases (1)
- Cell biology (1)
- Clinical frailty scale (1)
- Cofactors (biochemistry) (1)
- Colorectal cancer (1)
- Complicated stage (1)
- Computerlinguistik (1)
- Concurrent chemoradiotherapy (1)
- Conservation (1)
- Data sharing (1)
- Detergents (1)
- Devic disease (1)
- Devic syndrome (1)
- Devisenmarkt (1)
- Diabetes mellitus (1)
- Diagnostic markers (1)
- Digestive system (1)
- Digitization (1)
- EGFL7 (1)
- EWSR1 (1)
- Eignungsprüfung (1)
- Electronic properties and materials (1)
- Endoscopy (1)
- Experimental models of disease (1)
- Fluid overload (1)
- Frailty (1)
- Freundschaft, Begriff (1)
- Frühgeborenes (1)
- G-protein (1)
- GARCH-Prozess (1)
- Gait analysis (1)
- Gastfreundschaft (1)
- Gastfreundschaft <Motiv> (1)
- Gastfreundschaft, Begriff (1)
- Gene fusion (1)
- Generic NLP Architecture (1)
- Gomphus flavipes (1)
- HCV (1)
- HPSG Parsing (1)
- Health care resource utilization (1)
- Heme (1)
- Herbaria (1)
- Hippocampal volume (1)
- Hypertension (1)
- IE (1)
- Immunogenetics (1)
- Induction chemotherapy (1)
- Intensive care outcome (1)
- Intensive care treatment (1)
- Intestinal neoplasms (1)
- Joint loading (1)
- Kaukasische Völker (1)
- Kindheit (1)
- Kulturbeziehungen (1)
- Kunst (1)
- LEOSS (1)
- Libellen (1)
- Literatur (1)
- Liver diseases (1)
- Low birth weight infant (1)
- MN1 (1)
- MR-proADM (1)
- Machine learning (1)
- Magnetic properties and materials (1)
- Mechanisms of disease (1)
- Medizinstudium (1)
- Membrane proteins (1)
- Metabolic syndrome (1)
- Mild cognitive impairment (1)
- Molecular biology (1)
- Molecular marker (1)
- Monitoring (1)
- Mortality (1)
- Multiple choice Fragen (1)
- Multivariate analysis (1)
- NAFLD (1)
- NHEJ (1)
- NMO-IgG (1)
- NMR spectroscopy (1)
- Nephrons (1)
- Neugeborenes (1)
- Neuroepithelial (1)
- Neuromyelitis optica (1)
- Neurooncology (1)
- Obesity (1)
- Oncogenes (1)
- Oncology (1)
- Ophiogomphus cecilia (1)
- Orphan disease (1)
- Osteoarthritis (1)
- PATZ1 (1)
- Pediatric (1)
- Periodontal disease (1)
- Periodontal therapy (1)
- Phase transitions and critical phenomena (1)
- Phospho-tau (1)
- Plasminogen (1)
- Platelets (1)
- Portal veins (1)
- Prediction (1)
- Predictive model (1)
- Prostaglandin (1)
- Proteases (1)
- Protein structure (1)
- Proteolysis (1)
- Prüfungserfolg (1)
- Psychiatric disorders (1)
- RNA (1)
- RNA stem-loop structure (1)
- RNA-binding proteins (1)
- Radical nephrectomy (1)
- Ratewahrscheinlichkeit (1)
- RealTime (1)
- Renal cancer (1)
- Renal system (1)
- Research Infrastructure (1)
- Research article (1)
- Respimat® Soft Mist™ Inhaler (1)
- Respiratory signs and symptoms (1)
- Rho/Rho-kinase (1)
- S100 calcium‑binding protein B (1)
- SARS CoV 2 (1)
- SOFA (1)
- STAR GARCH (1)
- STED superresolution (1)
- STK3 (1)
- Self-expandable metal stents (1)
- Self-expandable metal stents complications (1)
- Semantics (1)
- Sepsis (1)
- Septic shock (1)
- Serum biomarker (1)
- Shallow NLP (1)
- Soft skills (1)
- Sowjetunion (1)
- Surgical and invasive medical procedures (1)
- Surgical oncology (1)
- Survival (1)
- Survival analysis (1)
- Survivin (1)
- TACE (1)
- TP53 mutation status (1)
- Tau (1)
- Taxonomy (1)
- Thrombosis (1)
- Thromboxane (1)
- Total hip arthroplasty (1)
- Translational research (1)
- Trauma (1)
- Tumor obstruction (1)
- UCN-01 (1)
- VIP1 (1)
- Validität (1)
- Veins (1)
- Viral load (1)
- Völkerverständigung (1)
- Wechselkurs (1)
- X-ray crystallography (1)
- X-ray structure analysis (1)
- XML (1)
- Zulassungskriterien (1)
- accessory proteins (1)
- acute myeloid leukemia (1)
- acute-on-chronic liver failure (1)
- admission criteria (1)
- admission test (1)
- advanced care planning (1)
- angiogenesis (1)
- anilinopyrimidine (1)
- aquaporin-4 (AQP4) antibody (1)
- bacterial translocation (1)
- benzazepinone (1)
- cell-free protein synthesis (1)
- centrosome (1)
- centrosome linker (1)
- cerebrospinal fluid (1)
- childhood (1)
- chronic granulomatous disease (1)
- cirrhosis (1)
- clinical features (1)
- comorbidities (1)
- critically ill patients (1)
- day clinic (1)
- device handling (1)
- edentulous (1)
- endothelial cell (1)
- epidemiology (1)
- examination success (1)
- fibrosis (1)
- full-arch restoration (1)
- glioblastoma (1)
- global change (1)
- guessing likelihood (1)
- habitat destruction (1)
- hematopoietic cells (1)
- hospital admission (1)
- human biology and medicine (1)
- in situ gene correction (1)
- inflammation (1)
- inhalation flow profiles (1)
- integrin (1)
- intrinsically disordered region (1)
- lactate dehydrogenase (1)
- land use (1)
- lasso regression (1)
- learning strategies (1)
- longitudinally extensive transverse myelitis (1)
- loss-of-function (1)
- low birth weight infant (1)
- magnetic resonance imaging (1)
- male (1)
- mechanical ventilation (1)
- medical studies (1)
- melanoma (1)
- mitosis (1)
- molecular docking (1)
- monitoring (1)
- mortality (1)
- mouse (1)
- multimodal complex treatment (1)
- multiple choice question (1)
- myogenic tone (1)
- myogenic vasoconstriction (1)
- networks (1)
- neurological manifestations (1)
- neutralizing antibodies (1)
- newborn infant (1)
- nomogram (1)
- non-homologous end joining (1)
- nonlinearities (1)
- nonstructural proteins (1)
- offene Fragen (1)
- peri-implant disease (1)
- personalized medicine (1)
- premature infant (1)
- preschool children (1)
- prevalence (1)
- prognostic factor (1)
- protein kinase inhibitor (1)
- pulmonary failure (1)
- recurrent optic neuritis (1)
- respiratory disease (1)
- respiratory failure (1)
- risk factor progression (1)
- risk stratification (1)
- rootletin (1)
- sequential ALK-inhibitor therapy (1)
- short essay questions (1)
- signal transduction (1)
- single best choice question (1)
- soft skills (1)
- sorafenib (1)
- spike protein (1)
- stage (1)
- structural proteins (1)
- studentisches Lernverhalten (1)
- sulfamide (1)
- survival (1)
- systematic review (1)
- technical and fundamental trading (1)
- treatment (1)
- validity (1)
- variants of concern (1)
- vascular smooth muscle (1)
Institute
- Medizin (64)
- Physik (34)
- Biochemie, Chemie und Pharmazie (6)
- Biowissenschaften (5)
- Biochemie und Chemie (3)
- Pharmazie (3)
- Präsidium (3)
- Senckenbergische Naturforschende Gesellschaft (3)
- Biodiversität und Klima Forschungszentrum (BiK-F) (2)
- Zentrum für Arzneimittelforschung, Entwicklung und Sicherheit (ZAFES) (2)
Aims: Patients with cardiovascular comorbidities have a significantly increased risk for a critical course of COVID-19. As the SARS-CoV2 virus enters cells via the angiotensin-converting enzyme receptor II (ACE2), drugs which interact with the renin angiotensin aldosterone system (RAAS) were suspected to influence disease severity.
Methods and results: We analyzed 1946 consecutive patients with cardiovascular comorbidities or hypertension enrolled in one of the largest European COVID-19 registries, the Lean European Open Survey on SARS-CoV-2 (LEOSS) registry. Here, we show that angiotensin II receptor blocker intake is associated with decreased mortality in patients with COVID-19 [OR 0.75 (95% CI 0,59–0.96; p = 0.013)]. This effect was mainly driven by patients, who presented in an early phase of COVID-19 at baseline [OR 0,64 (95% CI 0,43–0,96; p = 0.029)]. Kaplan-Meier analysis revealed a significantly lower incidence of death in patients on an angiotensin receptor blocker (ARB) (n = 33/318;10,4%) compared to patients using an angiotensin-converting enzyme inhibitor (ACEi) (n = 60/348;17,2%) or patients who received neither an ACE-inhibitor nor an ARB at baseline in the uncomplicated phase (n = 90/466; 19,3%; p<0.034). Patients taking an ARB were significantly less frequently reaching the mortality predicting threshold for leukocytes (p<0.001), neutrophils (p = 0.002) and the inflammatory markers CRP (p = 0.021), procalcitonin (p = 0.001) and IL-6 (p = 0.049). ACE2 expression levels in human lung samples were not altered in patients taking RAAS modulators.
Conclusion: These data suggest a beneficial effect of ARBs on disease severity in patients with cardiovascular comorbidities and COVID-19, which is linked to dampened systemic inflammatory activity.
Background & Aims: In ACLF patients, an adequate risk stratification is essential, especially for liver transplant allocation, since ACLF is associated with high short-term mortality. The CLIF-C ACLF score is the best prognostic model to predict outcome in ACLF patients. While lung failure is generally regarded as signum malum in ICU care, this study aims to evaluate and quantify the role of pulmonary impairment on outcome in ACLF patients.
Methods: In this retrospective study, 498 patients with liver cirrhosis and admission to IMC/ICU were included. ACLF was defined according to EASL-CLIF criteria. Pulmonary impairment was classified into three groups: unimpaired ventilation, need for mechanical ventilation and defined pulmonary failure. These factors were analysed in different cohorts, including a propensity score-matched ACLF cohort.
Results: Mechanical ventilation and pulmonary failure were identified as independent risk factors for increased short-term mortality. In matched ACLF patients, the presence of pulmonary failure showed the highest 28-day mortality (83.7%), whereas mortality rates in ACLF with mechanical ventilation (67.3%) and ACLF without pulmonary impairment (38.8%) were considerably lower (p < .001). Especially in patients with pulmonary impairment, the CLIF-C ACLF score showed poor predictive accuracy. Adjusting the CLIF-C ACLF score for the grade of pulmonary impairment improved the prediction significantly.
Conclusions: This study highlights that not only pulmonary failure but also mechanical ventilation is associated with worse prognosis in ACLF patients. The grade of pulmonary impairment should be considered in the risk assessment in ACLF patients. The new score may be useful in the selection of patients for liver transplantation.
The study of neutron-induced reactions is of high relevance in a wide variety of fields, ranging from stellar nucleosynthesis and fundamental nuclear physics to applications of nuclear technology. In nuclear energy, high accuracy neutron data are needed for the development of Generation IV fast reactors and accelerator driven systems, these last aimed specifically at nuclear waste incineration, as well as for research on innovative fuel cycles. In this context, a high luminosity Neutron Time Of Flight facility, n_TOF, is operating at CERN since more than a decade, with the aim of providing new, high accuracy and high resolution neutron cross-sections. Thanks to the features of the neutron beam, a rich experimental program relevant to nuclear technology has been carried out so far. The program will be further expanded in the near future, thanks in particular to a new high-flux experimental area, now under construction.
High precision measurement of the radiative capture cross section of 238U at the n_TOF CERN facility
(2017)
The importance of improving the accuracy on the capture cross-section of 238U has been addressed by the Nuclear Energy Agency, since its uncertainty significantly affects the uncertainties of key design parameters for both fast and thermal nuclear reactors. Within the 7th framework programme ANDES of the European Commission three different measurements have been carried out with the aim of providing the 238U(n,γ) cross-section with an accuracy which varies from 1 to 5%, depending on the energy range. Hereby the final results of the measurement performed at the n_TOF CERN facility in a wide energy range from 1 eV to 700 keV will be presented.
Neutron-induced fission cross sections of 238U and 235U are used as standards in the fast neutron region up to 200 MeV. A high accuracy of the standards is relevant to experimentally determine other neutron reaction cross sections. Therefore, the detection effciency should be corrected by using the angular distribution of the fission fragments (FFAD), which are barely known above 20 MeV. In addition, the angular distribution of the fragments produced in the fission of highly excited and deformed nuclei is an important observable to investigate the nuclear fission process.
In order to measure the FFAD of neutron-induced reactions, a fission detection setup based on parallel-plate avalanche counters (PPACs) has been developed and successfully used at the CERN-n_TOF facility. In this work, we present the preliminary results on the analysis of new 235U(n,f) and 238U(n,f) data in the extended energy range up to 200 MeV compared to the existing experimental data.
The n_TOF facility operates at CERN with the aim of addressing the request of high accuracy nuclear data for advanced nuclear energy systems as well as for nuclear astrophysics. Thanks to the features of the neutron beam, important results have been obtained on neutron induced fission and capture cross sections of U, Pu and minor actinides. Recently the construction of another beam line has started; the new line will be complementary to the first one, allowing to further extend the experimental program foreseen for next measurement campaigns.
The aim of this work is to provide a precise and accurate measurement of the 238U(n,γ) reaction cross section in the energy region from 1 eV to 700 keV. This reaction is of fundamental importance for the design calculations of nuclear reactors, governing the behavior of the reactor core. In particular, fast reactors, which are experiencing a growing interest for their ability to burn radioactive waste, operate in the high energy region of the neutron spectrum. In this energy region most recent evaluations disagree due to inconsistencies in the existing measurements of up to 15%. In addition, the assessment of nuclear data uncertainty performed for innovative reactor systems shows that the uncertainty in the radiative capture cross section of 238U should be further reduced to 1–3% in the energy region from 20 eV to 25 keV. To this purpose, addressed by the Nuclear Energy Agency as a priority nuclear data need, complementary experiments, one at the GELINA and two at the n_TOF facility, were proposed and carried out within the 7th Framework Project ANDES of the European Commission. The results of one of these 238U(n,γ) measurements performed at the n_TOF CERN facility are presented in this work. The γ-ray cascade following the radiative neutron capture has been detected exploiting a setup of two C6D6 liquid scintillators. Resonance parameters obtained from this work are on average in excellent agreement with the ones reported in evaluated libraries. In the unresolved resonance region, this work yields a cross section in agreement with evaluated libraries up to 80 keV, while for higher energies our results are significantly higher.
New results are presented of the 234U neutron-induced fission cross section, obtained with high accuracy in the resonance region by means of two methods using the 235U(n,f) as reference. The recent evaluation of the 235U(n,f) obtained with SAMMY by L. C. Leal et al. (these Proceedings), based on previous n_TOF data [1], has been used to calculate the 234U(n,f) cross section through the 234U/235U ratio, being here compared with the results obtained by using the n_TOF neutron flux.
The 236U isotope plays an important role in nuclear systems, both for future and currently operating ones. The actual knowledge of the capture reaction of this isotope is satisfactory in the thermal region, but it is considered insufficient for Fast Reactor and ADS applications. For this reason the 236U(n, γ) reaction cross-section has been measured for the first time in the whole energy region from thermal energy up to 1 MeV at the n_TOF facility with two different detection systems: an array of C6D6 detectors, employing the total energy deposited method, and a FX1 total absorption calorimeter (TAC), made of 40 BaF2 crystals. The two n_TOF data sets agree with each other within the statistical uncertainty in the Resolved Resonance Region up to 800 eV, while sizable differences (up to ≃ 20%) are found relative to the current evaluated data libraries. Moreover two new resonances have been found in the n_TOF data. In the Unresolved Resonance Region up to 200 keV, the n_TOF results show a reasonable agreement with previous measurements and evaluated data.
The 33S(n,α)30Si cross section measurement, using 10B(n,α) as reference, at the n_TOF Experimental Area 2 (EAR2) facility at CERN is presented. Data from 0.01 eV to 100 keV are provided and, for the first time, the cross section is measured in the range from 0.01 eV to 10 keV. These data may be used for a future evaluation of the cross section because present evaluations exhibit large discrepancies. The 33S(n,α)30Si reaction is of interest in medical physics because of its possible use as a cooperative target to boron in Neutron Capture Therapy (NCT).